Skip to main content

letter

. 1988 May;29(5):695–696. doi: 10.1136/gut.29.5.695-a

Olsalazine and GI transit in UC.

PMCID: PMC1433639 PMID: 3396959

695

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Meyers S., Sachar D. B., Present D. H., Janowitz H. D. Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology. 1987 Dec;93(6):1255–1262. doi: 10.1016/0016-5085(87)90253-8. [DOI] [PubMed] [Google Scholar]
Rao S. S., Read N. W., Holdsworth C. D. Influence of olsalazine on gastrointestinal transit in ulcerative colitis. Gut. 1987 Nov;28(11):1474–1477. doi: 10.1136/gut.28.11.1474. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sandberg-Gertzén H., Järnerot G., Kraaz W. Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties. Gastroenterology. 1986 Apr;90(4):1024–1030. doi: 10.1016/0016-5085(86)90882-6. [DOI] [PubMed] [Google Scholar]
Selby W. S., Barr G. D., Ireland A., Mason C. H., Jewell D. P. Olsalazine in active ulcerative colitis. Br Med J (Clin Res Ed) 1985 Nov 16;291(6506):1373–1375. doi: 10.1136/bmj.291.6506.1373. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES